Microwave ablation as an efficient therapy for primary hyperparathyroidism: Efficacy and predictors of treatment success-Reference-Cited by-同舟云学术

Microwave ablation as an efficient therapy for primary hyperparathyroidism: Efficacy and predictors of treatment success

Published:2021-07-06 Issue:10 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Erturk Mehmet Sercan¹²^ORCID,Cekic Bulent³,Sarı Işılay Kalan¹,Pamuk Barıs Onder²

Affiliation:

1. Division of Endocrinology and Metabolism Department of Internal Medicine University of Health Sciences Antalya Training and Research Hospital Antalya Turkey

2. Division of Endocrinology and Metabolism Department of Internal Medicine Izmir Katip Celebi UniversityAtaturk Training and Research Hospital Izmir Turkey

3. Department of Radiology University of Health Sciences Antalya Training and Research Hospital Antalya Turkey

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14580

Reference20 articles.

1. Consequences of parathyroidectomy in patients with “mild” sporadic primary hyperparathyroidism

2. Hyperparathyroidism

3. Hyperparathyroidism

4. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop

5. Future Considerations and Directions for Thermal Ablative Technologies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Microwave ablation is a safe and effective method for primary hyperparathyroidism in pregnancy;Frontiers in Medicine;2024-01-17

2. Effectiveness and Safety of Microwave Ablation Therapy in Parathyroid Adenomas;The Arab Journal of Interventional Radiology;2023-01

3. Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors;Diagnostics;2022-05-24

4. Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism;Frontiers in Endocrinology;2021-12-01